Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism
Clinical Endocrinology · 2024-11 · 101 (5) · 409-442
DOI: 10.1111/cen.15097 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Endocrinology, online erschienen am 21.06.2024. Verfasst von Channa N Jayasena und 13 weiteren Autor:innen. Beteiligte Einrichtung: Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Hypogonadism, Endocrinology. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
Female hypogonadism (FH) is a relatively common endocrine disorder in women of premenopausal age, but there are significant uncertainties and wide variation in its management. Most current guidelines are monospecialty and only address premature ovarian insufficiency (POI); some allude to management in very brief and general terms, and most rely upon the extrapolation of evidence from the studies relating to physiological estrogen deficiency in postmenopausal women. The Society for Endocrinology commissioned new guidance to provide all care providers with a multidisciplinary perspective on managing patients with all forms of FH. It has been compiled using expertise from Endocrinology, Primary Care, Gynaecology and Reproductive Health practices, with contributions from expert patients and a patient support group, to help clinicians best manage FH resulting from both POI and hypothalamo‐pituitary disorders, whether organic or functional.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, UK.
- Department of Endocrinology, Diabetes & Metabolism, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
- Translational & Clinical Research Institute, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK.
- Community Gynaecology (NHS), Principal Medical Limited, Bicester, Oxfordshire, UK.
- Oxford Menopause Ltd, Ardington, Wantage, UK.
- Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Jayasena, C. N., Devine, K., Barber, K., Comninos, A. N., Conway, G. S., Crown, A., Davies, M. C., Ewart, A., Seal, L. J., Smyth, A., Turner, H. E., Webber, L., Anderson, R. A., & Quinton, R. (2024). Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clinical Endocrinology, 101(5), 409-442. https://doi.org/10.1111/cen.15097
Vancouver
Jayasena CN, Devine K, Barber K, Comninos AN, Conway GS, Crown A, et al. Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clinical Endocrinology. 2024;101(5):409-442. doi:10.1111/cen.15097
BibTeX
@article{Jayasena2024,
author = {Jayasena, Channa N and Devine, Kerri and Barber, Katie and Comninos, Alexander N and Conway, Gerard S and Crown, Anna and Davies, Melanie C and Ewart, Ann and Seal, Leighton J and Smyth, Arlene and Turner, Helen E and Webber, Lisa and Anderson, Richard A and Quinton, Richard},
title = {Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism},
journal = {Clinical Endocrinology},
year = {2024},
volume = {101},
number = {5},
pages = {409--442},
doi = {10.1111/cen.15097}
}
EUVIMED